{"downloaded": true, "htmlmade": false, "full": {"id": "30450671", "source": "MED", "pmid": "30450671", "pmcid": "PMC6340743", "fullTextIdList": {"fullTextId": "PMC6340743"}, "doi": "10.1111/bjh.15625", "title": "Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort.", "authorString": "Painschab MS, Kasonkanji E, Zuze T, Kaimila B, Tomoka T, Nyasosela R, Nyirenda R, Dhungel BM, Mulenga M, Chikasema M, Tewete B, Mtangwanika A, Chiyoyola S, Mhango W, Chimzimu F, Kampani C, Krysiak R, Shea TC, Montgomery ND, Fedoriw Y, Gopal S.", "authorList": {"author": [{"fullName": "Painschab MS", "firstName": "Matthew S", "lastName": "Painschab", "initials": "MS", "authorId": {"@type": "ORCID", "#text": "0000-0001-9175-7436"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}, {"affiliation": "University of North Carolina, Chapel Hill, NC, USA."}]}}, {"fullName": "Kasonkanji E", "firstName": "Edwards", "lastName": "Kasonkanji", "initials": "E", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Zuze T", "firstName": "Takondwa", "lastName": "Zuze", "initials": "T", "authorId": {"@type": "ORCID", "#text": "0000-0003-3780-0207"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Kaimila B", "firstName": "Bongani", "lastName": "Kaimila", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Tomoka T", "firstName": "Tamiwe", "lastName": "Tomoka", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}, {"affiliation": "University of Malawi College of Medicine, Blantyre, Malawi."}]}}, {"fullName": "Nyasosela R", "firstName": "Richard", "lastName": "Nyasosela", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Kamuzu Central Hospital, Lilongwe, Malawi."}}}, {"fullName": "Nyirenda R", "firstName": "Ruth", "lastName": "Nyirenda", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Kamuzu Central Hospital, Lilongwe, Malawi."}}}, {"fullName": "Dhungel BM", "firstName": "Bal M", "lastName": "Dhungel", "initials": "BM", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}, {"affiliation": "University of North Carolina, Chapel Hill, NC, USA."}, {"affiliation": "Kamuzu Central Hospital, Lilongwe, Malawi."}]}}, {"fullName": "Mulenga M", "firstName": "Maurice", "lastName": "Mulenga", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Kamuzu Central Hospital, Lilongwe, Malawi."}}}, {"fullName": "Chikasema M", "firstName": "Maria", "lastName": "Chikasema", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Tewete B", "firstName": "Blessings", "lastName": "Tewete", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Mtangwanika A", "firstName": "Asekanadziwa", "lastName": "Mtangwanika", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Chiyoyola S", "firstName": "Sarah", "lastName": "Chiyoyola", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Mhango W", "firstName": "Wilberforce", "lastName": "Mhango", "initials": "W", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Chimzimu F", "firstName": "Fred", "lastName": "Chimzimu", "initials": "F", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Kampani C", "firstName": "Coxcilly", "lastName": "Kampani", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Krysiak R", "firstName": "Robert", "lastName": "Krysiak", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}}}, {"fullName": "Shea TC", "firstName": "Thomas C", "lastName": "Shea", "initials": "TC", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "University of North Carolina, Chapel Hill, NC, USA."}}}, {"fullName": "Montgomery ND", "firstName": "Nathan D", "lastName": "Montgomery", "initials": "ND", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "University of North Carolina, Chapel Hill, NC, USA."}}}, {"fullName": "Fedoriw Y", "firstName": "Yuri", "lastName": "Fedoriw", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "University of North Carolina, Chapel Hill, NC, USA."}}}, {"fullName": "Gopal S", "firstName": "Satish", "lastName": "Gopal", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "UNC Project-Malawi, Lilongwe, Malawi."}, {"affiliation": "University of North Carolina, Chapel Hill, NC, USA."}, {"affiliation": "University of Malawi College of Medicine, Blantyre, Malawi."}]}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-9175-7436"}, {"@type": "ORCID", "#text": "0000-0003-3780-0207"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "3", "volume": "184", "journalIssueId": "2772764", "dateOfPublication": "2019 Feb", "monthOfPublication": "2", "yearOfPublication": "2019", "printPublicationDate": "2019-02-01", "journal": {"title": "British journal of haematology", "ISOAbbreviation": "Br J Haematol", "medlineAbbreviation": "Br J Haematol", "NLMid": "0372544", "ISSN": "0007-1048", "ESSN": "1365-2141"}}, "pubYear": "2019", "pageInfo": "364-372", "abstractText": "Outcomes for diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa (SSA) are poorly described. We report mature data from one of the first prospective SSA cohorts. Patients aged \u226518\u00a0years with DLBCL were enrolled in Malawi 2013-2017. Participants were treated with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy and concurrent antiretroviral therapy (ART) if positive for human immunodeficiency virus (HIV+). Eighty-six participants (mean age 47\u00a0years, standard deviation 13) were enrolled: 54 (63%) were male and 51 (59%) were HIV+, of whom 34 (67%) were on ART at DLBCL diagnosis. Median CD4 count was 0\u00b7113 cells\u00a0\u00d7\u00a010<sup>9</sup> /l (interquartile range [IQR] 0\u00b7062-0\u00b7227) and 25 (49%) had HIV viral load <400\u00a0copies/\u03bcl. Participants received median six cycles CHOP (IQR 4-6). No patients were lost to follow-up and the 2-year overall survival was 38% (95% confidence interval 28-49). In multivariable analyses, Eastern Cooperative Oncology Group performance status (PS) \u22652 and lactate dehydrogenase (LDH) >2\u00d7 upper limit of normal (ULN) were associated with mortality. HIV status was not associated with mortality. A simplified prognostic model of LDH >2\u00d7 ULN and PS \u22652 performed at least as well as the age-adjusted International Prognostic Index. DLBCL can be successfully treated in SSA and outcomes did not differ by HIV status. A simplified prognostic model prognosticates well and may be easier to use in resource-limited settings but requires validation.", "affiliation": "UNC Project-Malawi, Lilongwe, Malawi.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["Clinical Trial", "research-article", "Journal Article", "Research Support, N.I.H., Extramural", "Observational Study"]}, "grantsList": {"grant": [{"grantId": "P20 CA210285", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "R21 CA180815", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "L30 CA233709", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "K01 TW009488", "agency": "FIC NIH HHS", "acronym": "TW", "orderIn": "0"}, {"grantId": "U54 CA190152", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "D43 TW009340", "agency": "FIC NIH HHS", "acronym": "TW", "orderIn": "0"}, {"grantId": "U2G PS001965", "agency": "NCHHSTP CDC HHS", "acronym": "PS", "orderIn": "0"}, {"grantId": "P30 CA016086", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "UM1 CA121947", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "Y", "descriptorName": "HIV-1"}, {"majorTopic_YN": "Y", "descriptorName": "HIV Seropositivity", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Cyclophosphamide", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Vincristine", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Doxorubicin", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Prednisone", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Antineoplastic Combined Chemotherapy Protocols", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Anti-Retroviral Agents", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Disease-Free Survival"}, {"majorTopic_YN": "N", "descriptorName": "Survival Rate"}, {"majorTopic_YN": "N", "descriptorName": "Prospective Studies"}, {"majorTopic_YN": "N", "descriptorName": "Adult"}, {"majorTopic_YN": "N", "descriptorName": "Aged"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Malawi", "meshQualifierList": {"meshQualifier": {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "Y", "descriptorName": "Lymphoma, Large B-Cell, Diffuse", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}]}}]}, "keywordList": {"keyword": ["Human immunodeficiency virus", "Prognosis", "Chemotherapy", "Sub-Saharan Africa", "Diffuse Large B-cell Lymphoma"]}, "chemicalList": {"chemical": [{"name": "Anti-Retroviral Agents", "registryNumber": "0"}, {"name": "Doxorubicin", "registryNumber": "80168379AG"}, {"name": "Prednisone", "registryNumber": "VB0R961HZT"}, {"name": "Cyclophosphamide", "registryNumber": "8N3DW7272P"}, {"name": "Vincristine", "registryNumber": "5J49Q6B70F"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1111/bjh.15625"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6340743"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6340743?pdf=render"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1111/bjh.15625"}]}, "isOpenAccess": "N", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "6", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "authMan": "Y", "epmcAuthMan": "N", "nihAuthMan": "Y", "manuscriptId": "NIHMS990188", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "nct"}, "dateOfCompletion": "2019-10-29", "dateOfCreation": "2018-11-20", "firstIndexDate": "2018-11-19", "fullTextReceivedDate": "2020-10-21", "dateOfRevision": "2021-05-18", "electronicPublicationDate": "2018-11-18", "firstPublicationDate": "2018-11-18", "embargoDate": "2020-02-01"}, "abstract": "Outcomes for diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa (SSA) are poorly described. We report mature data from one of the first prospective SSA cohorts. Patients aged \u226518\u00a0years with DLBCL were enrolled in Malawi 2013-2017. Participants were treated with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy and concurrent antiretroviral therapy (ART) if positive for human immunodeficiency virus (HIV+). Eighty-six participants (mean age 47\u00a0years, standard deviation 13) were enrolled: 54 (63%) were male and 51 (59%) were HIV+, of whom 34 (67%) were on ART at DLBCL diagnosis. Median CD4 count was 0\u00b7113 cells\u00a0\u00d7\u00a010<sup>9</sup> /l (interquartile range [IQR] 0\u00b7062-0\u00b7227) and 25 (49%) had HIV viral load <400\u00a0copies/\u03bcl. Participants received median six cycles CHOP (IQR 4-6). No patients were lost to follow-up and the 2-year overall survival was 38% (95% confidence interval 28-49). In multivariable analyses, Eastern Cooperative Oncology Group performance status (PS) \u22652 and lactate dehydrogenase (LDH) >2\u00d7 upper limit of normal (ULN) were associated with mortality. HIV status was not associated with mortality. A simplified prognostic model of LDH >2\u00d7 ULN and PS \u22652 performed at least as well as the age-adjusted International Prognostic Index. DLBCL can be successfully treated in SSA and outcomes did not differ by HIV status. A simplified prognostic model prognosticates well and may be easier to use in resource-limited settings but requires validation.", "Keywords": ["Human immunodeficiency virus", "Prognosis", "Chemotherapy", "Sub-Saharan Africa", "Diffuse Large B-cell Lymphoma"], "journaltitle": "British journal of haematology", "authorinfo": ["Painschab MS", "Kasonkanji E", "Zuze T", "Kaimila B", "Tomoka T", "Nyasosela R", "Nyirenda R", "Dhungel BM", "Mulenga M", "Chikasema M", "Tewete B", "Mtangwanika A", "Chiyoyola S", "Mhango W", "Chimzimu F", "Kampani C", "Krysiak R", "Shea TC", "Montgomery ND", "Fedoriw Y", "Gopal S"], "title": "Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort."}